drugset / Trial / NCT01450111

To Evaluate the Pharmacokinetics and Safety/Tolerability of Lacosamide in 3 Dosages in Healthy Male Korean Subjects

NCT01450111

Phase 1 Completed 51 enrolled UCB Pharma
RandomizedParallel-groupDouble-blind

Summary

Primary objective of this trial was to investigate the pharmacokinetics of single dose and repeated dose applications of lacosamide in healthy male Korean subjects.

Timeline

Start
2008-11
Primary completion
2009-02
Completion
2009-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Lacosamide Other / unclassified 50 mg Oral
Subject Lacosamide Other / unclassified 100 mg Oral
Subject Lacosamide Other / unclassified 200 mg Oral

Indications